Status:
UNKNOWN
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Carcinogenesis
Oral Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using SOX-9 Inhibitor.
Detailed Description
To find out if there is prognostic value which to the performance of SOX-9 of oral cancer in Taiwan and provide some reference for future treatment. We anticipate to enroll 40 persons with normal ora...
Eligibility Criteria
Inclusion
- Dysplasia or cancer of the oral cavity.
Exclusion
- pregnant woman
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2014
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT01919567
Start Date
November 1 2011
End Date
April 1 2014
Last Update
December 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital research Ethics Committee
Taipei, Taiwan, 10048